As expected, low cash burn rate, hence on schedule for trial enlisting and follow up evaluations.
As stated by the company public announcements on several disclosures ptx's science is in 'pregnency mode', that is their drugs on trial are not needing, at current, further developement but rather validation alone.
Funded well to at least phase 2 in all trails, happy to hold and accumilate.
GLTAH
- Forums
- ASX - By Stock
- PTX
- Ann: December 2015 Appendix 4C - Quarterly
Ann: December 2015 Appendix 4C - Quarterly, page-4
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.3¢ |
Change
0.001(2.38%) |
Mkt cap ! $34.62M |
Open | High | Low | Value | Volume |
4.2¢ | 4.3¢ | 4.2¢ | $15.41K | 366.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 12984 | 4.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.3¢ | 103726 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 12984 | 0.042 |
3 | 544492 | 0.041 |
9 | 722543 | 0.040 |
5 | 870000 | 0.039 |
1 | 200000 | 0.038 |
Price($) | Vol. | No. |
---|---|---|
0.043 | 103726 | 3 |
0.044 | 29944 | 1 |
0.045 | 72000 | 2 |
0.046 | 162500 | 2 |
0.049 | 209694 | 3 |
Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online